<DOC>
	<DOCNO>NCT01972243</DOCNO>
	<brief_summary>Because high recurrence risk unprovoked venous thromboembolism ( VTE ) indefinite anticoagulation recommend , confers considerable bleed risk . It important identify patient , recurrence risk lower expect bleeding risk , benefit long term anticoagulation . By use score model ( Vienna Prediction Model ) , patient stratify accord recurrence risk base sex , location VTE D-Dimer . Before implementation routine care , independent validation require . Patients unprovoked VTE stop anticoagulation 3-7 month recurrence risk estimate use Vienna Prediction Model . Low risk patient score &lt; 180 include left untreated . Patients high score include management follow current guideline . Follow-up two year endpoint recurrent symptomatic VTE .</brief_summary>
	<brief_title>Risk Recurrent Venous Thrombosis : A Validation Study Vienna Prediction Model</brief_title>
	<detailed_description />
	<mesh_term>Thromboembolism</mesh_term>
	<mesh_term>Venous Thromboembolism</mesh_term>
	<criteria>Age &gt; 18 year symptomatic uni bilateral proximal ( include trifurcation area , popliteal , superficial femoral , deep femoral , common femoral iliac vein ) distal DVT leg and/or symptomatic PE . VTE provoke one follow temporary risk factor : surgery , trauma , pregnancy , cancer , immobilisation . History previous VTE ; anticoagulation longer 6 month ; reason longterm anticoagulation VTE ; poor patient compliance ; consent participate</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2013</verification_date>
	<keyword>risk recurrent</keyword>
</DOC>